For example, only 24% of TP53mut MDS with < 5% harbored multi‐hit TP53 inactivation compared to 67%, 91%, and 71% of cases with blasts 5%–9%, 10%–19%, and ≥ 20%, respectively [26]. This evidence concerns the gene TP53 and myelodysplastic syndrome.